Ellen J. B. Derissen

Concise Drug Review: Azacitidine and Decitabine

Ellen J. B. Derissen, Jos H. Beijnen, Jan H.M. Schellens · The Oncologist · 2013 · 294 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Exploring the intracellular pharmacokinetics of the 5‐fluorouracil nucleotides during capecitabine treatment

Ellen J. B. Derissen, Bart Jacobs, Alwin D. R. Huitema et al. · British Journal of Clinical Pharmacology · 2015 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2′,2′‐difluorodeoxyuridine and their nucleotides

Ellen J. B. Derissen, Alwin D. R. Huitema, Hilde Rosing et al. · British Journal of Clinical Pharmacology · 2018 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immuno-affinity purification from human serum

Carola W.N. Damen, Ellen J. B. Derissen, Jan H.M. Schellens et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 37 citations

Pharmacy, Biochemistry, Immunology +17

Development of an LC–MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil

Ellen J. B. Derissen, M. J. X. Hillebrand, Hilde Rosing et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 31 citations · Full text

Medicine, Oncology, Pharmacology +14